MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Monday, September 23, 2019

1:45pm-3:15pm
Effect of Balanced Based Torso Weighting on gait in parkinsonism

D. Safarpour, M. Mancini, C. Murchison, S. Wood, A. Lesher, J. Duda, J. Morley (Philadelphia, PA, USA)

Other  ·  Agora 2 West, Level 2
1:45pm-3:15pm
Effect of dopamine D2-receptor antagonist and basal ganglia neuromodulation on neuronal activity in the cerebral motor area and cerebellar dentate nucleus

K. Schwabe, A. Abdulbaki, S. Helgers, J. Krauss, M. Alam (Hannover, Germany)

Neuropharmacology  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Effect of gastrointestinal surgery on the pharmacokinetics of levodopa in Parkinson’s disease

N. Miyaue, M. Nomoto, H. Yabe, Y. Yamanishi, S. Tada, R. Ando, M. Kubo, M. Nagai (Ehime, Japan)

Neuropharmacology  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Effect of Medication Review on Reported Symptoms in Parkinson’s disease Patients

C. Stuijt, T. Laar (Groningen, Netherlands)

Other  ·  Agora 2 West, Level 2
1:45pm-3:15pm
Effect of Once-Daily Opicapone on the Pharmacokinetics of Repaglinide

G. Loewen, G. Liang, R. Jimenez, K. Olson, E. Smith, H. Bozigian (San Diego, CA, USA)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Effect of opicapone in Parkinson’s disease patients with ‘early’ motor fluctuations: Parkinson’s Disease Questionnaire (PDQ-39) analysis from the BIPARK-I double-blind experience

J. Rocha, E. Tolosa, J. Ferreira, A. Lees, O. Rascol, W. Poewe, A. Santos, D. Magalhães, P. Soares-da-Silva (Coronado, Portugal)

Clinical Trials, Pharmacology and Treatment  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Effect of pill box organizers with alarm on improvement of adherence to pharmacotherapy in patients with Parkinson’s disease: a pilot study

I. Straka, M. Minár, M. škorvánek, M. Grofik, J. Benetin, P. Valkovič (Bratislava, Slovakia)

Neuropharmacology  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Effect of polygenic load on striatal dopaminergic deterioration in Parkinson’s disease

KJ. Pak, MJ. Lee (Busan, Republic of Korea)

Genetics  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Effect of Rehabilitation on Freezing of Gait in Parkinson’s disease: A meta-analysis

M. Gilat, P. Ginis, N. D'Cruz, A. Nieuwboer (Leuven, Belgium)

Physical and Occupational Therapy  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Effect of Speech therapy in the sleep of patients with Machado-Joseph disease (MJD) or spinocerebellar ataxia type 3 (SCA3)

G. Diaféria, JL. Pedroso, S. Park, F. Haddad, L. Haddad, L. Prado, G. Prado, O. Barsottini (São Paulo, Brazil)

Restless Leg Syndrome, RBD and Other Sleep Disorders  ·  Les Muses Terrace, Level 3
  • «Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 75
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley